Bringing the fundamentals into focus…
Back to Phreesia, Inc.
How Phreesia, Inc. stacks up
PHR · against 1,216 other Healthcare companies
Growth
75/ 100
Above the middle of the pack.
Ranked #299 of 1,217 · scores higher than 75% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 70–79, including PHR · Click a bar to see the companies
Why growth scores 75?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Earnings per share growth is not reported, so it is left out of the score.
- faster revenue growth over the last year: stronger than 71% of peers. Revenue growth: 14.5% vs peer median 6.1%
- faster revenue growth over three years: stronger than 81% of peers. 3-year revenue growth: 19.6% vs peer median 5.8%
Metric by metric
Position: dot = PHR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PHR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 14.5% | 6.1% | 71% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 19.6% | 5.8% | 81% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around PHR| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 299 | 2.2B USD | 75 | 78 | |
| 299 | 4.7B USD | 75 | 46 | |
| 299 | 749M USD | 75 | 39 | |
| 299 | 13.9B EUR (≈$15.3B) | 75 | 78 | |
| 299 | 759M USD | 75 | 54 | |
| 299 | 35.4B INR (≈$425M) | 75 | 67 | |
| 312 | 1.62T KRW (≈$1.2B) | 74 | 50 | |
| 312 | 193.6B HKD (≈$24.8B) | 74 | 78 | |
| 312 | 7.0B SAR (≈$1.9B) | 74 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score